Cubist Pharmaceuticals Inc. was just poking along as a drug-discovery company focused on anti-infectives until, in 1997, it bought rights to Eli Lilly & Co. 's phase II antibiotic, daptomycin [S
Small companies are staking out niches where they think they can do a better job of turning hits into leads than Big Pharma. by Mary Stuart More than once, the nightly news has reported that a new dis